{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T10:40:09Z","timestamp":1736678409114,"version":"3.32.0"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T00:00:00Z","timestamp":1166054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmazie in unserer Zeit"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cimetidin war der erste therapeutisch eingesetzte \u201cS\u00e4ureblocker\u201d und revolutionierte vor etwa 30 Jahren die Therapie peptischer Erkrankungen. \u00dcber systematische und rationale Optimierungsstrategien werden die Wege zum ersten Wirkstoff mit Marktreife und zu weiteren Entwicklungen aufgezeigt. Hierbei spielen Affinit\u00e4t, Bioverf\u00fcgbarkeit und Interaktionen besondere Rollen.<\/jats:p>","DOI":"10.1002\/pauz.200600201","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T11:17:37Z","timestamp":1166095057000},"page":"24-32","source":"Crossref","is-referenced-by-count":5,"title":["Medizinische Chemie von Histamin\u2010H<sub>2<\/sub>\u2010Rezeptorantagonisten: Klassische Wirkstoffentwicklung"],"prefix":"10.1002","volume":"36","author":[{"given":"Holger","family":"Kubas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,12,14]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Cooper D.G. Young R.C. Durant G.J. Ganellin C.R.: Histamin receptors. In: Comprehensive medicinal chemistry. In: Hansch C. Emmett J.C. (Eds.) Pergamon Press. Oxford U.K. (1990) pp. 323\u2010421."},{"key":"e_1_2_1_3_2","unstructured":"Classen M.: Ranitidin \u2013 Dokumentation eines Erfolges. Verlag f\u00fcr Medizin Dr. Ewald Fischer Heidelberg (1992)."},{"key":"e_1_2_1_4_2","unstructured":"Schwartz J.\u2010C. Haas H.L.: The histamine receptor. Wiley\u2010Liss Inc. New York (1992)."},{"key":"e_1_2_1_5_2","unstructured":"Sigma\u2010RBI eHandbook http:\/\/sigma\u2010aldrich.com\/ehandbook (15.08.2006)."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.13.6.851"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(95)00006-3"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00140a001"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0031-6997(24)01328-0","article-title":"International Union of Pharmacology XIII: Classification of histamine receptors.","volume":"49","author":"Hill","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_1_10_2","unstructured":"Mitchell D.: Medical Advisory Panel Drug Class Review H2\u2010Receptor Antagonists. In: Davis S. Barriuso P. Glassman P. (Eds.) http:\/\/www.pbm.va.gov\/reviews\/h2review.pdf (15.08.2006)."},{"key":"e_1_2_1_11_2","first-page":"1021","article-title":"Cimetidine, an unexpected anti\u2010tumor agent, and its potential for the treatment of glioblastoma.","volume":"28","author":"Lefranc F.","year":"2006","journal-title":"Int. J. Oncol."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706440"},{"key":"e_1_2_1_13_2","first-page":"9A","article-title":"Pharmacology of H2\u2010receptor antagonists: An overview.","volume":"17","author":"Schunack W.","year":"1989","journal-title":"J. Int. Med. Res."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70004-7"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389557043403242"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0184"}],"container-title":["Pharmazie in unserer Zeit"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpauz.200600201","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pauz.200600201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T10:13:39Z","timestamp":1736676819000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pauz.200600201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,14]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1002\/pauz.200600201"],"URL":"https:\/\/doi.org\/10.1002\/pauz.200600201","archive":["Portico"],"relation":{},"ISSN":["0048-3664","1615-1003"],"issn-type":[{"type":"print","value":"0048-3664"},{"type":"electronic","value":"1615-1003"}],"subject":[],"published":{"date-parts":[[2006,12,14]]}}}